Stockspot's Chris Brycki made a calculator showing how an indexation approach could hit after-tax returns from shares, gold ...

Discover the key differences between saving and investing and how your choice impacts your ability to retire. Learn how to ...

Compounding is the most powerful force in long-term investing. This beginner's guide explains how it works in stocks, ...

A recent op-ed in the Washington Post describes the story of an author who decided he wanted to lose weight. Although he was healthy, he heard from friends how easy and effective GLP-1 medications ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up for Dispatches, a newsletter that spotlights wrongdoing around the country, to receive our stories in your inbox every ...

Is peptide liberation day near, at long last? For the past month, wellness and longevity enthusiasts have eagerly waited for the federal government to loosen restrictions on some of the trendy and ...

As GLP-1 medications grow in popularity not just for treating diabetes but also for weight loss, some people are turning to alternatives that health experts warn may carry risks. Amelia Baker, a ...

Drugmaker Eli Lilly says some copycat versions of its GLP-1 medications pose unique safety concerns — here’s what you need to know. A new study funded by Eli Lilly found that mixing compounded ...

The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1 drug compounding. In its latest offensive, the agency has unleashed a fresh set of 30 warning letters targeting ...

People who order low-cost versions of the wildly popular weight-loss drugs Wegovy and Zepbound from so-called compounding pharmacies might soon see disruptions in their medication. The U.S. Food and ...

Novo Nordisk has sued Hims for allegedly violating patents protecting semaglutide, seeking potentially “hundreds of millions” in damages, John Kuckelman, the pharma’s general counsel, said. The ...

In the ever-evolving world of investing, identifying quality stocks that can deliver long-term compounding returns remains a cornerstone strategy for savvy traders. Recently, investment expert ...